Medicine and Dentistry
Patient
100%
Infection
97%
Anti-biotics
58%
Sepsis
49%
Indigenous
48%
Therapeutic Procedure
47%
Hepatitis B Virus
36%
Hospital
33%
Combination Therapy
29%
Mortality
22%
Randomized Controlled Trial
21%
Staphylococcus aureus
19%
Plasma
18%
Incidence
18%
Age
17%
COVID-19
17%
Diagnosis
17%
Diseases
17%
Physician
15%
Adult
15%
Methicillin Resistant Staphylococcus Aureus Infection
15%
Bacteremia
14%
Clinician
13%
Child
13%
Bloodstream Infection
13%
Chronic Hepatitis B
13%
Prosthetics
13%
Hepatitis B
13%
Clinical Trial
13%
Experience
12%
Pneumonia
12%
Hepatitis C
12%
Genotype
12%
Infusion
11%
Debridement
11%
Athletic Training
11%
Antibiotic Therapy
11%
Hepatitis B Antigen
10%
Analysis
10%
Association
10%
Inpatient
10%
β-Lactam antibiotic
9%
Arginine
9%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Pediatrics
8%
Meropenem
8%
Lactam
8%
Infectious Arthritis
8%
Consent
8%
Cohort Analysis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vancomycin
21%
Antibiotic Agent
17%
Sepsis
15%
Randomized Controlled Trial
14%
Infection
14%
Mortality
12%
Methicillin Resistant Staphylococcus Aureus Infection
11%
Bacteremia
10%
Acute Kidney Failure
9%
Pneumonia
9%
Lactam
9%
Antibiotics
9%
Methicillin-Resistant Staphylococcus Aureus
8%
Pharmacokinetics
8%
Meropenem
7%
Clinical Trial
6%
Staphylococcus Aureus
6%
Community Acquired Pneumonia
6%
Respiratory Tract Infection
6%
Gentamicin
6%
Antiinfective Agent
5%
Bronchitis
5%
Daptomycin
5%
Diseases
5%
Hospital Mortality
5%
Survival
5%
Observational Study
5%
Nursing and Health Professions
Patient
39%
Sepsis
14%
Indigenous
12%
Infusion
11%
Infection
11%
Procedures
10%
Beta Lactam Antibiotic
9%
Inpatient
7%
Hospital
6%
Intensive Care Unit
6%
Mortality
6%
Diagnosis
6%
Antibiotic Agent
5%
Time
5%
Consultation
5%
Confidence Interval
5%
Acute Bronchitis
5%
Standard
5%
